During an encounter with the sentient painting, the Mona Lisa at the International Gallery, a simulation of K9 Mk IV was created when Mona Lisa was tricked into animating a drawing of K9 made by Clyde inside a cloud of mystic drawing-animation energy. He subsequently defeated The Abomination, another evil painting-come-to-life, before disappearing as the Mona Lisa herself reverted to being an immobile painting. (TV: Mona Lisa's Revenge)
Although John Leeson has been the primary voice actor for K9 since his introduction, two other actors have voiced the character. David Brierley voiced K9 during Season 17 after Leeson chose not to return to the series (Leeson subsequently signed up again for Season 18), and Roy Skelton, better known for his work voicing Daleks, voiced the character in Destiny of the Daleks when all was required of K9 was a croaking sound due to the character contracting a form of robot laryngitis.
Within the series' narrative, K9 is a robot dog acquired by Doctor Who's title character in the 1977 serial The Invisible Enemy. The first two incarnations of the character travelled alongside the Fourth Doctor (portrayed by Tom Baker) until 1981. In these stories, K9 proved useful for the powerful laser weapon concealed in his nose, his encyclopaedic knowledge and his vast computer intelligence. By 1981, each of the two models of K9 which travelled alongside the Doctor had been left with one of the Doctor's female companions. The character subsequently transitioned into spin-off territory. Producers hoped K9's popularity with children would launch the series K9 and Company, led by actress Elisabeth Sladen in the role of companion Sarah Jane Smith alongside a new K9. In 2006, K9 reappeared in the revived series of Doctor Who. Although the character's appearances in the 2007 spin-off The Sarah Jane Adventures were hampered by the concurrent development of the K9 spin-off, the character began to appear full-time in both K9 and The Sarah Jane Adventures, depicting adventures of the original K9 Mark I and of Mark IV, respectively.